Status:
RECRUITING
Cavo-Tricuspid Isthmus Block Durability After Pulsed Electric Field Ablation
Lead Sponsor:
Institute for Clinical and Experimental Medicine
Conditions:
Flutter, Atrial
Cavotricuspid Isthmus Dependent Right Atrial Flutter
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study seeks to assess the acute durability of the CTI block when PEF energy is used. Second goal is to establish the optimal waiting time for the conduction recovery after PEF CTI ablation and to...
Detailed Description
Background Cavo-tricuspid isthmus (CTI) ablation is commonly performed as a concomitant procedure in patients undergoing pulmonary vein isolation (PVI) or more extensive left atrial ablations for the ...
Eligibility Criteria
Inclusion Criteria:
- patients with paroxysmal AF undergoing PVI by PEF energy with documented typical atrial flutter or patients with persistent AF in whom catheter ablation of CTI is planned as a part of a complex procedure
- Age ≥ 18 years at the time of study enrollment
- Signed informed consent
Exclusion Criteria:
- - LA diameter > 65 mm (measured in the parasternal long-axis view)
- History of CTI ablation in the past
- History of cardiac valve surgery
- Significant valvular defect
- Age below 18 years
- Pregnancy, breastfeeding
- Any disease with a life expectancy <1 year
- Uncorrected congenital heart disease or valvular obstruction
- Active myocarditis
- Untreated hypothyroidism or hyperthyroidism
- Recipient of any major organ transplant (e.g., lung, liver, heart)
- HIV positivity with a survival expectancy of less than five years due to HIV
- Chronic dialysis treatment
- Unwillingness to participate.
Key Trial Info
Start Date :
September 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06691074
Start Date
September 16 2024
End Date
December 31 2025
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Clinical and Experimental Medicine
Prague, Prague, Czechia, 14200